Found 11 matching trials
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma PHASE2 The purpose of this real-world study is to evaluate the safety and efficacy...
Show More Location
Zhongda Hospital, Southeast University
Learn More & Join Trial
Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases PHASE1 Trans arterial chemoembolization (TACE) has emerged as a treatment option f...
Show More Location
Pardis Noor Medical Imaging and Cancer Center
Learn More & Join Trial
Survival Analysis: TACE vs. Combination Therapy in HCC N/A This retrospective observational study aimed to assess potential improvemen...
Show More Location
First Affiliated Hospital, Medical College of Zhejiang University
Learn More & Join Trial
Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma N/A The purpose of this observational study is to evaluate properties of lipiod...
Show More Location
Zhongda Hospital, Southeast University
Learn More & Join Trial
TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma NA This study investigates the clinical efficacy and safety of transarterial c...
Show More Location
The First Hospital of Hebei Medical University
Learn More & Join Trial
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma NA In this study, patients with hepatocellular carcinoma were used as the rese...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib:A Prospective, Single-arm, Multicenter, Observational Study N/A To clarify the safety and efficacy of using uniform-sized drug-loaded embol...
Show More Location
People's Hospital of Kaiyang County
Learn More & Join Trial
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma PHASE2 Little is known about whether the types of chemotherapeutic agents affect t...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas PHASE1 The purpose of this study is to determine the maximal tolerated dose of ida...
Show More Location
Centre Hospitalier Universitaire de DIJON
Learn More & Join Trial
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma PHASE2 This is a single-arm, multicenter, exploratory clinical study evaluating th...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial